Home / Filing-delay notices (10-Q) / PharmaCyte Biotech, Inc.
Filed 2025-12-15 路 Form NT 10-Q 路 Accession 0001683168-25-009154 nano
Price before filing: $1.02 (2025-12-12 close, split/dividend-adjusted)
Market cap at flag: $8.7M (2025-12-15) 路 Latest: $3.7M (2026-10-16)
| Window | PMCB | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -10.3% | +1.6% | -11.9% | 2026-01-14 |
| 90 days | -31.3% | -1.6% | -29.7% | 2026-03-16 |
| 180 days | -20.5% | +11.3% | -31.9% | 2026-06-15 |
| 1 year | pending | pending | until 2026-12-15 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
The company filed Form NT 10-Q, telling the SEC it could not file its quarterly report on time, and then filed the report within the 5-day extension. The SEC treats a report filed within the extension as timely, so this is the mildest kind of flag, but the notice itself is a warning sign that investors often react to: something, often the audit or the accounting, took longer than planned.
Status: filed within extension (report filed 2025-12-18) · the SEC treats a report filed within the extension as timely
Why this score: report filed within the extension on 2025-12-18
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.